A BILL 
To direct the Secretary of Health and Human Services to 
carry out a national project to prevent and cure Parkin-
son’s, to be known as the National Parkinson’s Project, 
and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘National Plan to End 
4
Parkinson’s Act’’. 
5
00:45 Aug 11, 2022
H8585
2 
•HR 8585 IH
SEC. 2. NATIONAL PARKINSON’S PROJECT. 
1
(a) DEFINITION OF PARKINSON’S.—In this section, 
2
the term ‘‘Parkinson’s’’ means— 
3
(1) Parkinson’s disease; and 
4
(2) Parkinsonisms, including multiple system 
5
atrophy, Lewy body disease, corticobasal degenera-
6
tion, progressive supranuclear palsy, and Parkin-
7
son’s-related dementia. 
8
(b) ESTABLISHMENT.—The Secretary of Health and 
9
Human Services (in this section referred to as the ‘‘Sec-
10
retary’’) shall carry out a national project to prevent and 
11
cure Parkinson’s, to be known as the National Parkinson’s 
12
Project (referred to in this section as the ‘‘Project’’). 
13
(c) ACTIVITIES CARRIED OUT THROUGH PROJECT.— 
14
In carrying out the Project, the Secretary shall— 
15
(1) create, maintain, and periodically update an 
16
integrated national plan to prevent and cure Parkin-
17
son’s; 
18
(2) carry out the annual assessment under sub-
19
section (d); 
20
(3) evaluate all Federal programs related to 
21
Parkinson’s, including budget requests and approv-
22
als; 
23
(4) provide information (including an estimate 
24
of the level of Federal investment necessary to pre-
25
vent and cure Parkinson’s), and coordination of Par-
26
00:45 Aug 11, 2022
H8585
3 
•HR 8585 IH
kinson’s research and services, across all Federal 
1
agencies; 
2
(5) accelerate the development of treatments 
3
and other approaches to prevent, halt, or reverse the 
4
course of, Parkinson’s; 
5
(6) improve the— 
6
(A) early diagnosis of Parkinson’s; and 
7
(B) coordination of the care and treatment 
8
of individuals with Parkinson’s; 
9
(7) ensure the inclusion of populations at high-
10
er risk for Parkinson’s, or least likely to receive a 
11
diagnosis or care with respect to Parkinson’s, in 
12
clinical, research, and implement service efforts to 
13
decrease health disparities with respect to Parkin-
14
son’s; 
15
(8) review the impact of Parkinson’s on the 
16
physical, mental, and social health of those living 
17
with Parkinson’s and their care partners; 
18
(9) review social determinants of health, diver-
19
sity, equity, and inclusion associated with Parkin-
20
son’s; and 
21
(10) coordinate with international bodies to in-
22
tegrate and inform the global mission to prevent and 
23
cure Parkinson’s. 
24
00:45 Aug 11, 2022
H8585
4 
•HR 8585 IH
(d) ANNUAL
ASSESSMENT.—Not later than 18 
1
months after the date of enactment of this Act, and annu-
2
ally thereafter, the Secretary shall carry out an assess-
3
ment of the Nation’s progress in preparing for and re-
4
sponding to the escalating burden of Parkinson’s, includ-
5
ing— 
6
(1) the formulation of recommendations for pri-
7
ority actions based on the assessment; 
8
(2) a description of the steps that have been or 
9
should be taken to implement the recommendations; 
10
and 
11
(3) such other items as the Secretary deems ap-
12
propriate. 
13
(e) ADVISORY COUNCIL.— 
14
(1) IN GENERAL.—The Secretary shall establish 
15
and maintain an Advisory Council on Parkinson’s 
16
Research, Care, and Services (referred to in this sec-
17
tion as the ‘‘Advisory Council’’). 
18
(2) MEMBERSHIP.— 
19
(A) FEDERAL
MEMBERS.—The Advisory 
20
Council shall be comprised of diverse and inclu-
21
sive representatives from— 
22
(i) the Centers for Disease Control 
23
and Prevention; 
24
(ii) the Administration on Aging; 
25
00:45 Aug 11, 2022
H8585
5 
•HR 8585 IH
(iii) the Centers for Medicare & Med-
1
icaid Services; 
2
(iv) the Indian Health Service; 
3
(v) the Office of the Director of the 
4
National Institutes of Health; 
5
(vi) the National Institute of Neuro-
6
logical Disorders and Stroke; 
7
(vii) the National Institute of Envi-
8
ronmental Health Sciences; 
9
(viii) the National Institute on Aging; 
10
(ix) the National Science Foundation; 
11
(x) the Department of Veterans Af-
12
fairs; 
13
(xi) the Food and Drug Administra-
14
tion; 
15
(xii) the Department of Defense; 
16
(xiii) the Environmental Protection 
17
Agency; 
18
(xiv) the Office of Minority Health; 
19
and 
20
(xv) other relevant agencies as deter-
21
mined by the Secretary. 
22
(B) NON-FEDERAL
MEMBERS.—In addi-
23
tion to the members listed in subparagraph (A), 
24
the Advisory Council shall include 17 expert 
25
00:45 Aug 11, 2022
H8585
6 
•HR 8585 IH
members from outside the Federal Government, 
1
to be appointed by the Secretary, which mem-
2
bers shall include— 
3
(i) 4 Parkinson’s patient advocates, 
4
one of whom is living with young-onset 
5
Parkinson’s; 
6
(ii) 2 Parkinson’s family caregivers; 
7
(iii) 2 health care providers; 
8
(iv) 2 representatives of State health 
9
departments; 
10
(v) 2 biomedical researchers with Par-
11
kinson’s-related 
expertise 
in 
basic, 
12
translational, clinical, or drug development 
13
science; 
14
(vi) 1 movement disorder specialist 
15
who treats Parkinson’s patients; 
16
(vii) 1 dementia specialist who treats 
17
Parkinson’s patients; and 
18
(viii) 3 representatives, one from each 
19
of 3 nonprofit organizations that have 
20
demonstrated experience in Parkinson’s re-
21
search or Parkinson’s patient care and 
22
other services. 
23
(3) MEETINGS.— 
24
00:45 Aug 11, 2022
H8585
7 
•HR 8585 IH
(A) QUARTERLY
MEETINGS.—The Advi-
1
sory Council shall meet at least once each quar-
2
ter. 
3
(B) ANNUAL
RESEARCH
MEETING.—The 
4
Advisory Council shall convene an annual meet-
5
ing of Federal and non-Federal organizations to 
6
discuss Parkinson’s research. 
7
(C) OPEN
MEETINGS.—The meetings of 
8
the Advisory Council shall be open to the pub-
9
lic. 
10
(4) ADVICE.—The Advisory Council shall advise 
11
the Secretary on Parkinson’s-related issues. 
12
(5) ANNUAL
REPORT.—Not later than 15 
13
months after the date of enactment of this Act and 
14
annually thereafter, the Advisory Council shall pro-
15
vide to the Secretary and Congress a report con-
16
taining— 
17
(A) an evaluation of all federally funded ef-
18
forts in Parkinson’s research, prevention, clin-
19
ical care, and institutional-, home-, and commu-
20
nity-based programs and the outcomes of such 
21
efforts; 
22
(B) recommendations for priority actions 
23
to expand, eliminate, coordinate, refocus, or 
24
00:45 Aug 11, 2022
H8585
8 
•HR 8585 IH
condense Federal programs based on each pro-
1
gram’s performance, mission, and purpose; 
2
(C) recommendations to— 
3
(i) reduce the financial impact of Par-
4
kinson’s on— 
5
(I) the Medicare program and 
6
other federally funded programs; and 
7
(II) families living with Parkin-
8
son’s; 
9
(ii) improve health outcomes; 
10
(iii) prevent Parkinson’s; and 
11
(iv) eliminate exposure to environ-
12
mental triggers of Parkinson’s; and 
13
(D) an evaluation of the implementation, 
14
including outcomes, of the national plan under 
15
subsection (c)(1). 
16
(6) TERMINATION.—The Advisory Council shall 
17
terminate at the end of calendar year 2035. 
18
(f) DATA SHARING.—The Secretary may secure di-
19
rectly from any department or agency of the United States 
20
information necessary to enable the Secretary to complete 
21
the report under subsection (g). Upon request of the Sec-
22
retary, the head of that department or agency shall fur-
23
nish that information to the Secretary. 
24
00:45 Aug 11, 2022
H8585
9 
•HR 8585 IH
(g) ANNUAL REPORT.—The Secretary shall submit 
1
to the Congress— 
2
(1) an annual report that includes an evalua-
3
tion of all federally funded efforts in Parkinson’s re-
4
search, prevention, diagnosis, treatment, clinical 
5
care, and institutional-, home-, and community- 
6
based programs and the outcomes of such efforts; 
7
(2) an evaluation of all such programs based on 
8
performance, mission, and purpose; 
9
(3) recommendations for— 
10
(A) priority actions based on the evalua-
11
tion conducted by the Secretary and the Advi-
12
sory Council to— 
13
(i) reduce the financial impact of Par-
14
kinson’s on— 
15
(I) the Medicare program and 
16
other federally funded programs; and 
17
(II) families living with Parkin-
18
son’s disease; 
19
(ii) improve health outcomes; 
20
(iii) prevent Parkinson’s; and 
21
(iv) eliminate exposure to environ-
22
mental triggers of Parkinson’s; 
23
(B) priority actions to improve all federally 
24
funded efforts in Parkinson’s research, preven-
25
00:45 Aug 11, 2022
H8585
10 
•HR 8585 IH
tion, diagnosis, treatment, clinical care, and in-
1
stitutional-, home-, and community-based pro-
2
grams; and 
3
(C) implementation steps to address pri-
4
ority actions described in subparagraphs (A) 
5
and (B); and 
6
(4) an up-to-date version of the national plan 
7
under subsection (c)(1). 
8
(h) SUNSET.—The section shall cease to be effective 
9
at the end of calendar year 2035. 
10
Æ 
00:45 Aug 11, 2022
H8585
